LINAC Devices Market 2024 Latest Insights, Growth Rate, Future Trends And Forecast | Key Players : Accuracy Inc., Elekta AB, GE Healthcare Technologies Inc., Hitachi Ltd., Huiheng Medical Inc.

"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through LINAC Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The linac devices market size has grown strongly in recent years. It will grow from $4.79 billion in 2023 to $5.24 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to advancements in treatment delivery speed, standardization and regulation, growth in radiosurgery and stereotactic radiosurgery, enhanced safety features, improvements in imaging integration.

The linac devices market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rise in cancer incidences, development of adaptive radiotherapy, increasing demand for image-guided radiation therapy (igrt), enhanced safety and patient comfort, integration of artificial intelligence (ai). Major trends in the forecast period include innovative software solutions, adaptive radiotherapy development, telemedicine integration, incorporation of motion management, focus on patient-centric care.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10626&type=smp

Market Segmentation:
The linac devices market covered in this report is segmented -

1) By Product: High Energy, Low Energy, Medium Energy
2) By Method: Dedicated Linear Accelerator, Non-Dedicated Linear Accelerator
3) By Application: Breast Cancer, Colorectal Cancer, Head And Neck Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Clinics, Hospitals, Research Centers

Major Driver - Cancer Surge Drives Growth In The Linac Devices Market
Rising cancer cases is expected to propel the growth of the LINAC devices market forward. Cancer refers to a disease in which cells grow uncontrollably, and abnormal cells are spread in the body. Linear accelerators are used in radiation therapy to deliver external beam radiation (high-energy X-rays) at the cancer site to treat various cancers. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. , Therefore, the increased number of cancer cases is driving the LINAC devices market.

Competitive Landscape:
Major companies operating in the linac devices market report are Accuracy Inc., Elekta AB, GE Healthcare Technologies Inc., Hitachi Ltd., Huiheng Medical Inc., Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd., Top Grade Healthcare Group, Varian Medical Systems Inc., Siemens Healthineers GmbH, Shinva Medical Instrument Co. Ltd., Altair Technologies Inc., BEVATECH GmbH, CGN Dasheng Electron Accelerator Technology Company Limited, Diondo GmbH, IBA SA, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., Viewray Technologies Inc., MeVion Medical Systems Inc., Sumitomo Heavy Industries Ltd., ProNova Solutions LLC, RaySearch Laboratories AB, P-Cure Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, RefleXion Medical Inc., Nanobiotix S A, C-RAD AB, Theragenics Corporation, Isoray Inc., Nordion Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/linac-devices-global-market-report

Top Trend - Technological Advancements Unleashed In Linac Devices Market
Technological advancements were a key trend gaining popularity in the LINAC devices market. Major companies in the market are introducing products based on innovative technologies such as ViewRay MRIdian MRI-Guided Radiation Therapy System to sustain their position in the market. For instance, in March 2023, GenesisCare, a US-based cancer and cardiac care provider, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. MRIdian optimizes treatment such that fewer sessions may be necessary by combining precision radiation therapy with cutting-edge, high-resolution MRI guidance. The uniqueness of the product is that it is the first radiotherapy system with diagnostic-quality MRI with an advanced linear accelerator and provides access to the MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. LINAC Devices Market Characteristics
3. LINAC Devices Market Trends And Strategies
4. LINAC Devices Market - Macro Economic Scenario
5. LINAC Devices Market Size And Growth
…..
27. LINAC Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.